AIOCD
All India Organization of Chemists and Druggists (AIOCD) has expressed deep concern over the Central Government’s proposal to permit the sale of Over-The-Counter (OTC) drugs without a license in India.
In a detailed memorandum submitted to the Health Minister, Principal Health Secretary, Drug Controller General of India, Director General of Health Services, Chairman of the National Pharmaceutical Pricing Authority (NPPA), and other relevant authorities, AIOCD highlighted the significant risks associated with this proposal.
AIOCD President, JS Shinde and General Secretary Rajiv Singhal emphasized that such a move would contravene existing drug laws, pharmacy regulations, and pertinent legal frameworks, including directives from the Supreme Court.
Allowing OTC drug sales without proper regulation poses serious threats like dangerous self-medication and drug abuse, increased risk of adverse drug reactions and proliferation of counterfeit drugs and delayed access to healthcare services among others.
AIOCD has urged the government to consider the multifaceted implications of this proposal, emphasizing that unregulated availability of medications in general and grocery stores does not serve the best interests of society.
The central probe agency CBI on Wednesday unearthed a bribery racket at Delhi’s top centre-run…
The Indian Council of Medical Research on Wednesday released “Dietary Guidelines for Indians (DGIs)”, an…
The Union health ministry on Wednesday stressed on the importance of timely detection and prevention…
In an effort to raise awareness towards Thalassemia on the occasion of World Thalassemia Day,…
World Asthma Day, observed on the first Tuesday of May each year, draws attention to…
A report by KPMG Assurance and Consulting Services report titled Human-Centric Approach to Tobacco Control has revealed that India loses precious…